Our extensive testing and diverse patient population provides for useful information that has broad applicability.

The purpose of the BPC is to provide phenotype information for participants of the BioMe Biobank. The BioMe Biobank is an electronic medical record-linked biobank of over 45,000 participants in the New York City Area. Due to the ideal location of Mount Sinai Hospital, the participants are diverse and multi-ethnic. Through our extensive phenotyping protocol, we hope to facilitate discovery of genotype-phenotype associations which will ultimately advance personalized medicine.

Our phenotyping protocol is extensive and includes the following and more:

• Cardiovascular testing
• Blood testing for lipid disorders, diabetes, and banking of blood for future use
• Body imaging
• Metabolomics

We have aided researchers in patient recruitment and drug development. For more information on how BPC can be useful to you please fill out our form or contact us directly.

We are happy to work with collaborators both internal and external to advance their research.

The purpose of the BPC is to provide phenotype information for participants of the BioMe Biobank. The BioMe Biobank is an electronic medical record-linked biobank of over 40,000 participants in the New York City Area. Through our extensive phenotyping protocol, we are dedicated to improving the understanding of genotype-phenotype associations.

Our phenotyping protocol includes the following and more:

• Cardiovascular testing
• Blood testing for lipid disorders, diabetes, and banking of blood for future use
• Body imaging
• Metabolomics

The BPC will work with investigators to explore phenotypes associated with a myriad of genetic alleles. The BPC hopes to help collaborators bring their work from the bench back to the patient. The results will be useful for manuscript generation and can serve as preliminary data for grant applications.

Current and Past Research Projects:

1. Association of Coronary Artery Disease Polygenic Risk Score and Calcium Scores.
We are comparing the calcium scores obtained from cardiac CT scans of participants with high and low genetic risk for coronary artery disease.

2. Phenotyping of sub-clinical Heart Failure
Identification of sub-clinical heart failure using tests such as 99c-technetium pyrophosphate scans on genetically high-risk participants.

3. Mechanisms of Kidney Failure
Performing phenotypic testing and generating iPSCs on genetically susceptible patients for kidney failure.

4. Screening of High Genetic Risk Participants for Glaucoma
We are performing extensive vision testing and glaucoma screening in patients with high genetic risks of glaucoma to aid in the early identification of this disease.

For more information on how BPC can advance your research please fill out our form or contact us directly.

Your participation will not only further genetic research, but provide you with personalized information about your health status.

The purpose of the BPC is to determine if certain genes place people at increased or decreased risk of medical diseases. In order to do this, participants of BPC will undergo vigorous screening for medical disorders. Participants will be provided with a summary of their test results. Currently, the BPC is only recruiting patients from the BioMe Biobank at the Icahn School of Medicine at Mount Sinai.

For more information on BioMe please visit BioMe Biobank or email.